Literature DB >> 17570805

Communicating with women about mammography.

Berta M Geller1, Jane Zapka, Solveig S-H Hofvind, Astrid Scharpantgen, Livia Giordano, Noriaki Ohuchi, Rachel Ballard-Barbash.   

Abstract

BACKGROUND/
METHODS: We report survey results of the types of tools used to communicate with women about breast cancer screening and the content areas included in each tool for member countries of the International Breast Cancer Screening Network (IBSN).
RESULTS: In addition to using pamphlets and invitation letters, new technologies are being used such as the Internet which allows for easy updating of information and can provide interactive modules. Several countries have addressed the needs of specific populations such as indigenous populations or blind women. All countries provide basic information, although they do not provide all the same information.
CONCLUSION: More research is needed to understand what women need to make an informed decision about mammography and to learn what the best modalities are to provide this information.

Entities:  

Mesh:

Year:  2007        PMID: 17570805     DOI: 10.1007/BF03174371

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  20 in total

1.  Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2004-01-17

Review 2.  Personalised risk communication for informed decision making about entering screening programs.

Authors:  A Edwards; S Unigwe; G Elwyn; K Hood
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  The mammography screening controversy: who and what is heard in the press?

Authors:  Margaret Holmes-Rovner; Sonya Charles
Journal:  Patient Educ Couns       Date:  2003-09

4.  Women's perception of mammography screening.

Authors:  J-L Bulliard; F Levi
Journal:  Int J Epidemiol       Date:  2004-05-20       Impact factor: 7.196

5.  Print information to inform decisions about mammography screening participation in 16 countries with population-based programs.

Authors:  Jane G Zapka; Berta M Geller; Jean-Luc Bulliard; Jacques Fracheboud; Helene Sancho-Garnier; Rachel Ballard-Barbash
Journal:  Patient Educ Couns       Date:  2006-10

6.  Women's decision-making about their health care: views over the life cycle.

Authors:  Judith Belle Brown; June Carroll; Heather Boon; Jean Marmoreo
Journal:  Patient Educ Couns       Date:  2002-12

7.  Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.

Authors:  R Ballard-Barbash; C Klabunde; E Paci; M Broeders; E A Coleman; J Fracheboud; F Bouchard; G Rennert; S Shapiro
Journal:  Eur J Cancer Prev       Date:  1999-10       Impact factor: 2.497

8.  Is screening for breast cancer with mammography justifiable?

Authors:  P C Gøtzsche; O Olsen
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

9.  Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force.

Authors:  Stacey L Sheridan; Russell P Harris; Steven H Woolf
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

10.  Report of the International Workshop on Screening for Breast Cancer.

Authors:  S W Fletcher; W Black; R Harris; B K Rimer; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

View more
  3 in total

Review 1.  Communication between patients and providers and informed decision making.

Authors:  Joann G Elmore; Pamela S Ganschow; Berta M Geller
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Evaluating Population-Based Screening Mammography Programs Internationally.

Authors:  Carrie N Klabunde; Rachel Ballard-Barbash
Journal:  Semin Breast Dis       Date:  2007-06

3.  Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites.

Authors:  Alex Ghanouni; Susanne F Meisel; Jolyn Hersch; Jo Waller; Jane Wardle; Cristina Renzi
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.